I am seeing something perplexing, can you help? I am trying to call variants in plasmids. To do this I am using bowtie2, freebayes and an assortment of other tools. As a QC I’m initially using plasmids of known sequence and reads derived from them. I then introduce alterations in the reference plasmid sequence, align the reads and call variants. One of these altered plasmids has two 2kb exact repeats separated by ~2kb. Into the center of one of these, a 6bp insertion was introduced. The PE reads I then align (separately) come from 2 libraries, one of ~400bp insertions and the other ~800bp insertions. With the 400bp insert library, bowtie2 (in end-to-end mode) produces no gapped alignments that span the insert. With the 800bp insert library, it does. It is unclear to me why bowtie2 did not align these reads and their pairs to the other repeat, since the insert size is not long enough to anchor the pair outside the repeat and the other repeat would have provided a more perfect match (I am running bowtie2 in the default mode that reports only the best alignment). Speculating that the pairs aligning to this position might have longer than average inserts I examined the alignment with “tablet” but found, to the contrary, many have smaller than 800bp inserts. Can someone kindly explain this?
Unconfigured Ad
Collapse
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, Yesterday, 11:13 AM
|
0 responses
19 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 11:13 AM
|
||
|
Started by SEQadmin2, Yesterday, 10:48 AM
|
0 responses
18 views
0 reactions
|
Last Post
by SEQadmin2
Yesterday, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
36 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
42 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|